Track topics on Twitter Track topics that are important to you
Since 1983, Management Forum have built a reputation on providing the highest quality conference, seminar and knowledge-based experiences for leading professionals in some of the world's most...
FDA issues a Form 483 following inspection of Impax Laboratories' Hayward, CA facility. read more
Hana Biologics and Somatix combined their complementary technologies by merging into a new company named Somatix Therapy Corp., based in Alamada, CA. The stock-swap transaction is valued at approxima...
Sepracor has acquired IBF Biotechnics SA (biopharmaceutical purification products) from Rhone-Poulenc SA for $19.1 million consisting of a combination of cash, notes payable, warrants, and equity secu...
Genex Corporation (specialty pharmaceuticals) sold its Protein G business, used in affinity chromatography, to Pharmacia LKB Biotechnology for approximately $2 million.
Eli Lilly divested its 5% share in Synergen, selling 537,900 shares at $271/8 for gross proceeds of $14.6 million and a profit of $7.6 million.
Incyte Pharmaceuticals acquired the technology developed at Invitron's Redwood City, California laboratories, including technology developed by Invitron's Ideon subsidiary, for $1,225,000.
Applied bioTechnology (developing genetically-engineered products for the diagnosis and treatment of cancer) acquired Du Pont's 50% share of Oncogenetic Partners, their joint venture formed in 1986 to...
Abbott Laboratories has sold its remaining 2.5 million share stake in Amgen on the open market, reportedly on February 6 in a single transaction at $82 1/2 per share.